The size of the High-Performance Liquid Chromatography Market in Europe was around USD 1.19 Billion in 2020. It is expected to grow at a CAGR of 5.2% to reach USD 1.52 Billion by 2025.
The factors attributed to the growth of the European market are the developed healthcare infrastructure, the escalation in various industries over a period, the high rate of acquisition of technologically advanced products, and the escalation of healthcare expenditure and healthcare activities research expertise in the region. Higher sensitivity and precision compared to conventional chromatographic techniques are the significant factors that drive the growth of the European high-performance liquid chromatography market during the forecast period.
The higher penetration rate of high-performance liquid chromatography increased the popularity of LC-MS (liquid chromatography-mass spectrography), increased use of high-performance liquid chromatography in pharmaceuticals for manufacturing testing and quality control, The results and faster separation and technical advancement are among the other factors that will drive the growth of the European market till 2025. The increasing number of pharmaceuticals in developed and developing countries is expected to drive the European market growth in high-performance liquid chromatography.
The high cost of a high-performance liquid chromatography system is a significant factor that is expected to hamper the growth of the high-performance liquid chromatography market in Europe. Besides, the high cost associated with the service resulting in operating expenses is another crucial factor that is expected to limit the growth of the target market.
This research report on the European HPLC Market has been segmented and sub-segmented into the following categories:
By Product:
By Instruments:
By Consumables:
By Application:
By Country:
Regionally, Europe occupies the second largest market share after North America. Growing R&D activities and the presence of key players are likely to fuel the market expansion in Europe.
Europe is expected to capture a substantial share of the global HPLC market, attributed to increased investments by major players in the pharmaceutical and biotechnology industry and government intervention to control environmental and food safety. The European HPLC market is assured to seize nearly one-third of the overall global market share, growing at a CAGR of 5.2% during the forecast period. HPLC is a separation technique in which a liquid is used to force the sample at high pressure through a column filled with a stationary phase to identify and quantify the components. It has brought many advantages in the field of food analysis and the analysis of various fat-soluble vitamins. HPLC is also used in bioinformatics and DNA fingerprinting. Additionally, HPLC's high sensitivity and precision support its increasing adoption by law enforcement agencies to detect performance-enhancing drugs in urine, increasing the growth of the market. HPLC testing is gaining importance for drug approval, as many countries have started to focus on using this technology. Other factors, such as the growing popularity of the LC-MS technique and the increasing expenditure on R&D in the life sciences, are also driving the growth of the HPLC market.
Notable companies leading the European high-performance liquid chromatography market profiled in this report are Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific Inc., GE Healthcare, PerkinElmer Inc., Bio-Rad Laboratories Inc., Gilson Inc., Phenomenex Inc., and JASCO Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.2.1 Systems
5.1.2.2 Detectors
5.1.2.3 Pumps
5.1.2.4 Fraction Collectors
5.1.3 Consumables
5.1.3.1 Columns
5.1.3.2 Filters
5.1.3.3 Vials
5.1.3.4 Tubes
5.1.4 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Clinical research
5.2.3 Diagnostics
5.2.4 Forensics
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Waters Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Agilent Technologies
8.3 Shimadzu Corporation
8.4 Thermo Fisher Scientific Inc
8.5 GE Healthcare
8.6 PerkinElmer Inc.
8.7 Bio-Rad Laboratories Inc
8.8 Gilson Inc.
8.9 Phenomenex Inc.
8.10 JASCO Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
